| Type of Biological Sample |
Components / Analytes |
Examination Technique |
Examination Procedure |
Status |
| Biochemistry |
| | - Homogeneous enzyme immunoassay technique
| PL-CLC-PR-117 | Active
|
| | PL-CLC-PR-129 | Active
|
| - Colorimetric Kinetic Rate standardized against IFCC Reference Formulation
| PL-CLC-PR-072 | Active
|
- Alanine aminotransferase (ALT)
| - Colorimetric, standardized against IFCC Reference Formulation
| PL-CLC-PR-070 | Active
|
| - Enzymatic colorimetric assay IFCC compliant
| PL-CLC-PR-105 | Active
|
| | PL-CLC-PR-131 | Active
|
- Aspartate aminotransferase (AST)
| - Colorimetric, standardized against IFCC Reference Formulation
| PL-CLC-PR-174 | Active
|
| | PL-CLC-PR-107 | Active
|
| - Colorimetric - Diazo method
| PL-CLC-PR-168 | Active
|
| - Colorimetric Diazo method (special)
| PL-CLC-PR-180 | Active
|
| - Colorimetric Gen.2 NM-BAPTA
| PL-CLC-PR-123 | Active
|
| - Cloned enzyme donor immunoassay (CEDIA)
| PL-CLC-PR-122 | Active
|
| | PL-CLC-PR-132 | Active
|
| - Colorimetric Enzymatic Abell/Kendall &IDMS standardized
| PL-CLC-PR-120 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA"
| PL-CLC-PR-201 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-125 | Active
|
| PL-CLC-PR-124 | Active
|
| - Particle enhanced immunoturbidimetric assay
| PL-CLC-PR-109 | Active
|
| - Jaffe Rate kinetic colorimetric assay
| PL-CLC-PR-108 | Active
|
- Enzymatic colorimetric assay
| PL-CLC-PR-178 | Active
|
| - IFCC Colorimetric Enzymatic assay
| PL-CLC-PR-167 | Active
|
| - Particle enhanced immunoturbidimetric assay
| PL-CLC-PR-119 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-112 | Active
|
| - Kinetic interaction of microparticles in a solution(KIMS)
| PL-CLC-PR-147 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-115 | Active
|
| - Particle enhanced Immunoturbidimetric assay
| PL-CLC-PR-110 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-199 | Active
|
| - Kinetic interaction of microparticles (KIM) enhanced-immunoturbidimetric Immunoassay
| PL-CLC-PR-151 | Active
|
- Gamma-glutamyl transferase (GGT)
| - IFCC/ Szasz standardized colorimetric assay
| PL-CLC-PR-106 | Active
|
- Glucose, random fasting, 2 Hour Postprandial
| - Colorimetric Hexokinase assay
| PL-CLC-PR-075 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-150 | Active
|
| - Homogeneous enzymatic colorimetric test
| PL-CLC-PR-157 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-190 | Active
|
| PL-CLC-PR-182 | Active
|
| PL-CLC-PR-185 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-184 | Active
|
| | PL-CLC-PR-076 | Active
|
| | PL-CLC-PR-068 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-196 | Active
|
| | PL-CLC-PR-172 | Active
|
| - Colorimetric Xylidyl blue assay
| PL-CLC-PR-154 | Active
|
- NT-proB-type Natriuretic Peptide (BNP)
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-163 | Active
|
| - kinetic interaction of microparticles in a solution (KIMS)
| PL-CLC-PR-179 | Active
|
| - Kinetic interaction of microparticles (KIM) enhanced-immunoturbidimetric Immunoassay Cobas 8000
| PL-CLC-PR-187 | Active
|
| - Kinetic interaction of microparticles in a solution (KIMS)
| U71-SK-CHM-02-873 | Active
|
| | PL-CLC-PR-132 | Active
|
| | PL-CLC-PR-132 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-078 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-198 | Active
|
| PL-CLC-PR-188 | Active
|
| PL-CLC-PR-189 | Active
|
| PL-CLC-PR-148 | Active
|
| | PL-CLC-PR-099 | Active
|
| PL-CLC-PR-186 | Active
|
| | PL-CLC-PR-092 | Active
|
- Sex hormone binding globulin
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-158 | Active
|
| | PL-CLC-PR-132 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-175 | Active
|
| PL-CLC-PR-080 | Active
|
| | PL-CLC-PR-100 | Active
|
| PL-CLC-PR-327 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-094 | Active
|
| - Kinetic interaction of microparticles IN A SOLUTION (KIMS)
| PL-CLC-PR-095 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-096 | Active
|
| - Homogeneous enzyme immunoassay
| PL-CLC-PR-097 | Active
|
| - Phosphoenolpyruvate (PEP)
| U71-SK-CHM-319 | Active
|
| - Turbidimetric method Colorimetric
| PL-CLC-PR-170 | Active
|
| - Tina-quant Transferrin ver.2 Immunoturbidimetric assay
| U71-SK-CHM-333 | Active
|
| - Enzymatic colorimetric standardized- ID-MS
| PL-CLC-PR-155 | Active
|
- Thyroid peroxidase antibodies
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-197 | Active
|
| PL-CLC-PR-101 | Active
|
- Thyroid Stimulating Hormone, TSH
| U71-SK-CHM-809 | Active
|
| - Colorimetric Enzymatic Kinetic test ( urease and glutamate dehydrogenase)
| PL-CLC-PR-171 | Active
|
| - Homogeneous enzyme immunoassay
| PL-CLC-PR-102 | Active
|
| - Kinetic interaction of microparticles in a solution (KIMS)
| PL-CLC-PR-103 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-144 | Active
|
| - Enzymatic Urease colorimetric assay
| PL-CLC-PR-143 | Active
|
| - Homogeneous enzymatic colorimietric test
| PL-CLC-PR-156 | Active
|
| | PL-CLC-PR-279 | Active
|
| PL-CLC-PR-277 | Active
|
- Free Beta Human Chorionic Gonadotrophin
| | PL-CLC-PR-278 | Active
|
- Pregnancy-associated plasma protein (PAPP-A)
| | PL-CLC-PR-274 | Active
|
| | PL-CLC-PR-275 | Active
|
- Unconjugated (Free) Estriol
| | PL-CLC-PR-276 | Active
|
| | PL-CLC-PR-089 | Active
|
| PL-CLC-PR-090 | Active
|
| - Immunoturbidimetric assay
| U71-SK-CHM-02-343 | Active
|
| | - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-079 | Active
|
| PL-CLC-PR-073 | Active
|
| | PL-CLC-PR-077 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-192 | Active
|
| PL-CLC-PR-193 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-113 | Active
|
| - ElectrocheElectrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-145 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-135 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA"
| PL-CLC-PR-194 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-202 | Active
|
| PL-CLC-PR-200 | Active
|
| PL-CLC-PR-195 | Active
|
| - Rate Immunoturbidimetric Assay
| PL-CLC-PR-087 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-081 | Active
|
| - Kinetic interaction of microparticles (KIM) enhanced-immunoturbidimetric Immunoassay
| PL-CLC-PR-138 | Active
|
- Carcinoembryonic Antigen (CEA)
| - Electrochemiluminescence immunoassay “ECLIA”
| U71-SK-CHM-02-828 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-121 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-074 | Active
|
| PL-CLC-PR-126 | Active
|
| - Particle enhanced Immunoturbidimetric assay
| PL-CLC-PR-111 | Active
|
| | PL-CLC-PR-162 | Active
|
| | PL-CLC-PR-161 | Active
|
- Serum Protein Electrophoresis
| PL-CLC-PR-161 | Active
|
| - Immunoturbidimetric assay
| PL-CLC-PR-184 | Active
|
| | U71-SK-CHM-02-556 | Active
|
- Insulin-like growth factor binding protein 3 (IGFBP-3)
| - Chemiluminescence Immunoassay (CLIA)
| U71-SK-CHM-559 | Active
|
| - Enzyme-linked immunosorbent assay (ELISA)
| PL-CLC-PR-118 | Active
|
| PL-CLC-PR-139 | Active
|
| - Freezing point depression
| U71-SK-CHM-02-107 | Active
|
| | U71-SK-CHM-02-414 | Active
|
| U71-SK-CHM-02-415 | Active
|
| - Enzyme-linked immunosorbent assay (ELISA)
| U71-SK-CHM-02-661 | Active
|
| | PL-CLC-PR-326 | Active
|
| PL-CLC-PR-326 | Active
|
| | - Chemiluminescence Immunoassay (CLIA)
| U71-SK-CHM-557 | Active
|
| - Adrenocorticotropic hormone (ACTH)
| PL-CLC-PR-069 | Active
|
| | PL-CLC-PR-130 | Active
|
| - Enzyme-linked immunosorbent assay (ELISA) Manual
| PL-CLC-PR-141 | Active
|
| | | PL-CLC-PR-322 | Active
|
| - Chemiluminescence Immunoassay (CLIA)
| PL-CLC-PR-153 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-149 | Active
|
| - IFCC standardized Turbidimetric inhibition immunoassay (TINIA)
| PL-CLC-PR-173 | Active
|
| - Chemiluminescence Immunoassay (CLIA)
| U71-SK-CHM-848 | Active
|
| - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-093 | Active
|
| PL-CLC-PR-165 | Active
|
| | | PL-CLC-PR-116 | Active
|
| | PL-CLC-PR-159 | Active
|
| | - Immunoturbidimetric assay
| PL-CLC-PR-071 | Active
|
| - Enzymatic colorimetric assay IFCC compliant
| PL-CLC-PR-105 | Active
|
| - Colorimetric Gen.2 NM-BAPTA
| PL-CLC-PR-123 | Active
|
| - Jaffe Rate kinetic colorimetric assay
| U71-SK-CHM-322 | Active
|
| - Formula based calculation
| PL-CLC-PR-167 | Active
|
| | PL-CLC-PR-132 | Active
|
| - Colorimetric Xylidyl blue assay
| PL-CLC-PR-154 | Active
|
| | U71-SK-CHM-331 | Active
|
| | PL-CLC-PR-132 | Active
|
| U71-SK-CHM-106 | Active
|
| - Turbidimetric method Colorimetric
| U71-SK-CHM-334 | Active
|
| - Colorimetric Enzymatic Kinetic test ( urease and glutamate dehydrogenase)
| PL-CLC-PR-171 | Active
|
| - Enzymatic Urease colorimetric assay
| U71-SK-CHM-337 | Active
|
- Catecholamines, 24 hour urine/ Random urine
| | PL-CLC-PR-088 | Active
|
| PL-CLC-PR-088 | Active
|
| PL-CLC-PR-088 | Active
|
| U71-SK-CHM-614 | Active
|
- 5-Hydroxyindoleacetic acid (5-HIAA)
| PL-CLC-PR-104 | Active
|
- Urine (24 hr and random))
| | U71-SK-CHM-613 | Active
|
- Norepinephrine (Noradrenaline)
| PL-CLC-PR-088 | Active
|
| PL-CLC-PR-091 | Active
|
- Vanillylmandelic Acid (VMA)
| PL-CLC-PR-104 | Active
|
| | | PL-CLC-PR-132 | Active
|
| - Colorimetric Hexokinase assay
| PL-CLC-PR-075 | Active
|
| - Immunoturbidimetric assay
| U71-SK-CHM-146 | Active
|
| | PL-CLC-PR-159 | Active
|
| U71-SK-CHM-328 | Active
|
| | U71-SK-CHM-334 | Active
|
| | - Colorimetric Hexokinase assay
| PL-CLC-PR-075 | Active
|
| - Triage® TOX Drug Screen Qualitative fluorescence immunoassay
| PL-CLC-PR-056
PL-TEC-IN-008 | Active
|
| PL-CLC-PR-205
PL-TEC-IN-008 | Active
|
| PL-CLC-PR-059
PL-TEC-IN-008 | Active
|
| - Qualitative fluorescence immunoassay Triage
| PL-CLC-PR-058
PL-TEC-IN-008 | Active
|
| - Triage® TOX Drug Screen Qualitative fluorescence immunoassay
| PL-CLC-PR-058
PL-TEC-IN-008 | Active
|
- EDDP (Methadone Metabolite)
| U71-SK-CHM-766 | Active
|
| U71-SK-CHM-766 | Active
|
| PL-CLC-PR-057
PL-TEC-IN-008 | Active
|
| PL-TEC-IN-008 | Active
|
| | PL-CLC-PR-136 | Active
|
| | U71-SK-CHM-765 | Active
|
| - Benedict’s copper reduction qualitative method Manual
| U71-SK-CHM-767 | Active
|
| - Freezing point depression
| U71-SK-CHM-02-107 | Active
|
| | PL-CLC-PR-209 | Active
|
| PL-CLC-PR-60 | Active
|
| | - Enzymatic Colorimetric assay
| PL-CLC-PR-164 | Active
|
| - Occult blood / haemoglobin
| - Quantitative faecal immunochemical test (FIT)
| PL-CLC-PR-177 | Active
|
| | - Enzyme-linked immunosorbent assay (ELISA)
| PL-CLC-PR-152 | Active
|
| - Benedict’s copper reduction qualitative method Manual
| U71-SK-CHM-767 | Active
|
| | | U71-SK-CHM-421 | Active
|
| U71-SK-CHM-421 | Active
|
| | | U71-SK-CHM-02 -344 | Active
|
| U71-SK-CHM-02 -345 | Active
|
| | | PL-CLC-PR-203 | Active
|
| Biochemistry/ Serology |
| | - Electrochemiluminescence immunoassay “ECLIA”
| PL-CLC-PR-128 | Active
|
| PL-CLC-PR-084 | Active
|
| PL-CLC-PR-082 | Active
|
| PL-CLC-PR-083 | Active
|
| PL-CLC-PR-085 | Active
|
| POCT (C5, OR, Cath Lab) |
| | | PL-POCT-PR-003 | Active
|
| POCT (C5, OR, Cath Lab, Ed A, ED Crit, A4, D0, C4 ) |
| | | PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| PL-POCT-PR-008 | Active
|
| PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| | PL-POCT-PR-008 | Active
|
| PL-POCT-PR-008 | Active
|
| POCT (ED A, ED Crit, ED Peds) |
| | | PL-POCT-PR-007 | Active
|
| | PL-POCT-PR-007 | Active
|
| | PL-POCT-PR-007 | Active
|
| | PL-POCT-PR-007 | Active
|
| PL-POCT-PR-007 | Active
|
| POCT (DO,ED,C5) |
| | - Electrochemical system (electrode)
| PL-POCT-PR-010 | Active
|
| POCT (All Areas) |
| | | PL-POCT-PR-016 | Active
|
| POCT (Diabetic Clinic) |
| | | PL-POCT-PR-017 | Active
|
| POCT (OSC 9 (AC Clinic)) |
| | | PL-POCT-PR-024 | Active
|
| POCT (ED, OSC 3, OSC 13, C5, OSC-VIP) |
| | | PL-POCT-PR-021 | Active
|
| POCT (ED, OSC 13, C5, OSC-VIP) |
| | | PL-POCT-PR-019 | Active
|
| POCT (ED, OSC 3, OSC 13, Diabetic, C5, OSC-VIP ) |
| | | PL-POCT-PR-022 | Active
|
| POCT (ED, OSC 3, OSC 13,OSC-VIP) |
| | | PL-POCT-PR-020 | Active
|
| POCT (B1 (Endoscopy Clinic)) |
| | | PL-POCT-PR-009 | Active
|
| POCT (ED, A2, A4, D0, C2, C5, OSC 3, Osc 12, OSC 6, Diabetic Clinic, F2) |
| | | PL-POCT-PR-027 | Active
|
| POCT (ED, OSC, B1, Radiology, VIP, Diabetic Clinic) |
| | | PL-POCT-PR-006 | Active
|
| Hematology |
| | | PL-HEM-IN-026 | Active
|
| PL-HEM-PR-069, PL-HEM-PR-071 | Active
|
- Capillary Hb Electrophoresis
| PL-HEM-IN-010 | Active
|
| - New Methylene blue/manual
| PL-HEM-PR-080 | Active
|
| | PL-HEM-PR-006 | Active
|
| - Chromatographic card test/manual
| PL-HEM-PR-003 | Active
|
| | PL-HEM-PR-076 | Active
|
| - Calculated via cumulative pulse height detection method
| PL-HEM-PR-058 | Active
|
| | PL-HEM-PR-056 | Active
|
| | PL-HEM-PR-057 | Active
|
- Automated and Manual Reticulocyte Count
| - Flow cytometry and Manual
| PL-HEM-PR-059, PL-HEM-PR-081 | Active
|
| | PL-HEM-PR-060 | Active
|
| | PL-HEM-PR-058 | Active
|
| | PL-HEM-PR-010 | Active
|
| PL-HEM-PR-010 | Active
|
| PL-HEM-PR-010 | Active
|
| | PL-HEM-PR-060 | Active
|
| | PL-HEM-PR-060 | Active
|
| PL-HEM-PR-060 | Active
|
| PL-HEM-PR-060 | Active
|
| PL-HEM-PR-060 | Active
|
| PL-HEM-PR-060 | Active
|
| | PL-HEM-PR-059 | Active
|
| | PL-HEM-PR-057 | Active
|
| | PL-HEM-PR-058 | Active
|
| PL-HEM-PR-057 | Active
|
| - Enzymatic chromatographic test/Manual
| PL-HEM-PR-046 | Active
|
| - Digital Microsopy and Light Microscopy/Manual
| D-MD-LAB-07-250 and D-MD-LAB-07-304 | Active
|
| - Pathology Bone marrow Aspirate
| | PL-HEM-PR-045 | Active
|
| - CSF for Cranial Bleed Tube: Cell-RBC
| | D-MD-LAB-07-328 | Active
|
- CSF Hematology, Lumbar Puncture,CSF oncology: RBC ,Nucleated cell count, Differential nucleated cell count
| PL-HEM-PR-082 | Active
|
| - CSF Hematology, Shunt Fluid:RBC ,Nucleated cell count, Differential nucleated cell count
| PL-HEM-PR-082 | Active
|
- Citrated whole blood or citrated plasma
| | | PL-HEM-PR-051 | Active
|
| | PL-HEM-PR-008 | Active
|
| PL-HEM-PR-008 | Active
|
| | PL-HEM-PR-061 | Active
|
| | PL-HEM-PR-029 | Active
|
| PL-HEM-PR-052 | Active
|
| PL-HEM-PR-028 | Active
|
| PL-HEM-PR-027 | Active
|
| PL-HEM-PR-026 | Active
|
- Low Molecular weight Heparin
| | PL-HEM-PR-032 | Active
|
| | D-MD-LAB-07-347 | Active
|
| PL-HEM-PR-025 | Active
|
| | PL-HEM-PR-032 | Active
|
| | PL-HEM-PR-024 | Active
|
| PL-HEM-PR-016 | Active
|
| PL-HEM-PR-016 | Active
|
| PL-HEM-PR-022 | Active
|
| PL-HEM-PR-016 | Active
|
| PL-HEM-PR-030 | Active
|
- PTT-LA based Mixing study
| PL-HEM-PR-030 | Active
|
| | PL-HEM-PR-021 | Active
|
| | PL-HEM-PR-023 | Active
|
| | PL-HEM-PR-019 | Active
|
| PL-HEM-PR-019 | Active
|
| PL-HEM-PR-019 | Active
|
| PL-HEM-PR-050 | Active
|
| PL-HEM-PR-062 | Active
|
| | PL-HEM-PR-014 | Active
|
| | PL-HEM-PR-020 | Active
|
- Factor VIII chromogenic assay
| | PL-HEM-PR-009 | Active
|
| PL-HEM-PR-011 | Active
|
| PL-HEM-PR-011 | Active
|
| PL-HEM-PR-011 | Active
|
| PL-HEM-PR-011 | Active
|
- Body Fluid :EDTA Specimen/Heparin/sterile container without anticoagulant
| - RBC, Nucleated cell count, Differential count
| - RBC: Impedance, Nucleated cells and Diff : Flow Cytometry, Manual diff: Microscopy
| PL-HEM-PR-082 | Active
|
| Haematology Flowcytometry |
- EDTA Peripheral blood / BM / Fresh tissue / Body Fluids
| - Screening tube: Kappa, CD8, Lambda, CD4, CD19, CD56, CD10, CD14, CD34, CD5, CD20, CD33, CD117, CD3, CD45
| | 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- B Cell Tube: Kappa, Lambda, CD10, CD5, CD200, CD34, CD38, CD20, CD19, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- T Cell Tube : TCR g/d, CD4, CD2, CD56, CD5, CD34, CD7, CD8, CD3, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Myeloid M1 Tube: CD16, CD7, CD10, CD13, CD64, CD34, CD14, HLA-Dr, CD11b, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Myeloid M2 Tube: CD15, CD123, CD117, CD13, CD33, CD34, CD38, HLA-Dr, CD19, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Cytoplasmic screening Tube: Tdt, MPO, CD34, cyto CD3, CD19, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Myelomonocytic Tube: CD117, CD14, CD34, CD11c, CD33, CD36, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Cyto B: Cyto Tdt, Cyto CD22, CD34, cyto CD79a, CD19, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Cyto T: Cyto Tdt, CD19, CD1a,CD34, Cyto CD3, surface CD3, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- Plasma cell neoplasm Tube: cyto Kappa, cyto Lambda, CD117, CD27, CD56, CD38, CD19, CD28, CD138, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- HCL / CD5 & CD10 BCL Tube: CD43, CD10, CD23, CD25, CD19, CD103, CD11c, CD20, CD5 , CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- APL / Mega / Erythroid Tube: CD42a, CD42b, HLA-DR, CD61, CD41, CD34, CD71, CD117, CD9, CD36, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- NK / T-LGL Cell Tube: CD8, CD279, CD19, CD56, CD3, CD4, CD5, CD7, CD57, CD45
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- 6 color sceening tube: CD45, CD34, 7-AAD, CD19, CD3, CD33
| 10 color leukemia and lymphoma Analysis on the Navios EX Flow Cytometer (PL-FCM-PR-001) | Active
|
- CD4/CD8 testing: CD3, CD4, CD8, CD19, CD56
| Lymphopcyte Subset Analysis (LSA) Using Navios EX System (PL-FCM-PR-003) | Active
|
| - Leukocyte adhesion: CD11a, CD18, CD11b, CD11c
| Leukocyte Adhesion Test by Flowcytometry on Navios EX (PL-FCM-PR-005) | Active
|
- Platelet function studies: CD42a, CD42b, CD61, CD41a
| Platelet Dysfunction Test by Flowcytometry on Navios EX (PL-FCM-PR-009) | Active
|
- PNH: CD235a,CD59, Flaer,CD24,CD15, CD64, CD45, CD14
| PNH (Paroxysmal Nocturnal Haemoglobinuria) Test by Flowcytometry on Navios EX (PC-FCM-PR-010) | Active
|
| Immunohematology |
| - ABO and Rh Blood grouping
| - Gel Column Agglutination and Tube Agglutination
| U71-SK-TRM-02-201, U71SK-TRM-02-202, U71-SK-TRM-02-204, U71-SK-TRM-02-413 | Active
|
| U71-SK-TRM-02-205, U71-SK-TRM-02-206, U71-SK-TRM-02-413 | Active
|
| U71-SK-TRM-02-207, U71-SK-TRM-02-208 | Active
|
| | U71-SK-TRM-02-219 | Active
|
| U71-SK-TRM-02-215 | Active
|
- Direct Antiglobulin Test (DAT) Polyspecific
| U71-SK-TRM-02-213 | Active
|
- Direct Antiglobulin Test (DAT) Monospecific
| U71-SK-TRM-02-213 | Active
|
- Compatibility Testing (Crossmatch)
| - Gel Column Agglutination and Tube Agglutination
| U71-SK-TRM-02-211, U71-SK-TRM-02-221, U71-SK-TRM-02-228 | Active
|
| U71-SK-TRM-02-216, PL-BB-PR-013 | Active
|
| | U71-SK-TRM-06-220 | Active
|
| Serology |
| | - Chemiluminescence- Alinity i
| PL-SER-PR-120 | Active
|
| - Chemiluminescence- Alinitiy S
| PL-SER-PR-016 | Active
|
| - Chemiluminescence- Alinity i
| PL-SER-PR-126 | Active
|
| PL-SER-PR-142 | Active
|
| - Chemiluminescence- Alinity S
| PL-SER-PR-115 | Active
|
| - Chemiluminescence- Alinity i
| PL-SER-PR-058 | Active
|
| PL-SER-PR-127 | Active
|
| PL-SER-PR-124 | Active
|
| PL-SER-PR-056 | Active
|
| PL-SER-PR-057 | Active
|
| - Chemiluminescence- Alinity S
| PL-SER-PR-054 | Active
|
| PL-SER-PR-084 | Active
|
| PL-SER-PR-125 | Active
|
| PL-SER-PR-085 | Active
|
| - Chemiluminescence- Alinity i
| PL-SER-PR-005 | Active
|
| PL-SER-PR-006 | Active
|
| PL-SER-PR-092 | Active
|
| PL-SER-PR-008 | Active
|
| PL-SER-PR-003 | Active
|
| PL-SER-PR-004 | Active
|
| PL-SER-PR-017 | Active
|
| PL-SER-PR-055 | Active
|
| PL-SER-PR-009 | Active
|
| | PL-SER-PR-101 | Active
|
| PL-SER-PR-100 | Active
|
| PL-SER-PR-028 | Active
|
| PL-SER-PR-029 | Active
|
| PL-SER-PR-069 | Active
|
| | PL-SER-PR-104 | Active
|
| | PL-SER-PR-102 | Active
|
| PL-SER-PR-112 | Active
|
| PL-SER-PR-129 | Active
|
| PL-SER-PR-098 | Active
|
| | PL-SER-PR-102 | Active
|
| PL-SER-PR-112 | Active
|
| PL-SER-PR-129 | Active
|
| PL-SER-PR-098 | Active
|
| PL-SER-PR-111 | Active
|
- Mycoplasma pneumoniae IgM
| PL-SER-PR-108 | Active
|
| PL-SER-PR-030 | Active
|
| PL-SER-PR-066 | Active
|
| PL-SER-PR-002 | Active
|
- HIV 1/2 Immunodiferentiation Assay
| - Lateral flow immunochromatography- Geenius
| PL-SER-PR-010 | Active
|
| PL-SER-PR-061 | Active
|
| | PL-SER-PR-086 | Active
|
| PL-SER-PR-067 | Active
|
| | | PL-SER-PR-099 | Active
|
| Microbiology |
- Broncho-Alveolar Lavage (BAL), Endo-tracheal aspirate (ET Aspirate), Sputum, Urine
| | - Screening by CHROM Agar-Acinetobacter (MDR), confirmation by Identification & Susceptibility Testing
| D-MD-LAB-09-127/701/702/706/510/513 | Active
|
- Sputum, Bronchial Lavage and (Endo) Tracheal Aspirate, Sterile Fluids and CSF samples, Tissue Samples, Bone Marrow
| - AFS (Acid Fast Stain) smear
| - Fluorescent Staining (Auramine stain)
| D-MD-LAB-09-403 | Active
|
- AFB (Acid Fast Bacilli) Culture
| | D-MD-LAB-09-408/405/406/407/417/411/410/409/401/418 | Active
|
- Blood cultures (Pediatric Bottle & Set of Aerobic and Anaerobic Bottles)
| | - Gram stain, Culture bacterial aerobic, anaerobic and fungal (yeasts) with isolation, identification & Susceptibility tests of isolate- BACTEC, Vitek2 and Vitek MS
| D-MD-LAB-09-304/305/956/701/702/706/510/513/102 | Active
|
- Sterile body fluids (excluding urine and blood)
| - Body Fluid Culture with Aerobic and Anaerobic Culture
| - Gram stain, Culture bacterial, aerobic, anaerobic and fungal (yeast) with isolation, identification and susceptibility of isolatesVitek2 and Vitek MS
| D-MD-LAB-09-179/701/702/706/506 | Active
|
| | - Gram stain, Culture bacterial, aerobic, fungal (yeast) and AFB culture with isolation, identification and susceptibility of isolatesVitek2 and Vitek MS
| D-MD-LAB-09-178/506/701/702/706/513/510 | Active
|
- Corneal Scraping, Brain Tissue
| | - Smear, primary source with interpretation, fluorescent and/acid fast stain for fungi or parasites
| D-MD-LAB-09-953 | Active
|
| - C.difficile antigen and toxin A/B
| - Infectious agent antigen detection by enzyme immunoassay technique (antigen)
| D-MD-LAB-09-206 | Active
|
| - Smear, primary source with interpretation, fluorescent and/acid fast stain for parasites
| D-MD-LAB-09-212 | Active
|
- H.pylori Direct Detection Stool
| - Infectious agent antigen detection by enzyme immunoassay technique
| D-MD-LAB-09-205 | Active
|
| - Wet mount for cells (Saline)
| D-MD-LAB-09-201 | Active
|
| | D-MD-LAB-09-811 | Active
|
| | - Screening by CHROM Agar-CRE, confirmation by Identification & Susceptibility Testing
| D-MD-LAB-09-312/506/323//116/133/171/132/131 | Active
|
| - Screening by CHROM Agar-ESBL, confirmation by Identification & Susceptibility Testing
| D-MD-LAB-09-175/506/701/702/706/513/510 | Active
|
- Throat swab, Sputum, Tracheal Aspirate
| | - Culture bacterial, aerobic, anaerobic and fungal, with isolation, identification and susceptibility of isolates.
| D-MD-LAB-09-180/956/701/702/706/513/510 | Active
|
- Ear Swab, Fine Needle Aspirate, Genital Swabs, Genital discharges, Intra-Uterine Contraceptive Devices (IUCD), Medical devices, Oral swabs, Vitreous Humor, Wound swabs, Wound discharges, Surgical site swabs, Breast discharge
| - Culture, bacterial; any source except blood, urine, stool
| - Gram stain, Culture bacterial, aerobic, anaerobic and fungal, with isolation, identification, and susceptibility of isolates. The work-up is processed depending on the type of specimen.Vitek2 and Vitek MS
| D-MD-LAB-09-506/178/956/102/701/702/706/513/510 | Active
|
- Skin, hair, nails, Corneal Scraping
| | - Culture, fungi isolation, with presumptive identification of isolates. KOH slide of samples from skin, hair and nails. Fluorescent stain for fungi (Calcofluor White) from Corneal scraping
| D-MD-LAB-09-956/955/954 | Active
|
| | - Examination by KOH slide preparation from skin, hair or nails for fungi
| D-MD-LAB-09-955 | Active
|
| | - Smear, wet mount for infectious agents
| D-MD-LAB-09-104 | Active
|
- FilmArray® Meningitis/Encephalitis Panel
| | D-MD-LAB-09-814 | Active
|
- Skin swabs from Axilla, Groin, Hairline, Hand, Nasal, Perineum, Umbilicus
| | - Screening by CHROM Agar-MRSA, confirmation by Identification & Susceptibility TestingVitek2 and Vitek MS
| D-MD-LAB-09-123-701/702/706/513 | Active
|
| | - Ova and parasites, direct smears, concentration and identification
| D-MD-LAB-09-211 | Active
|
- Sputum, Broncho-alveolar lavage (BAL), Bronchial Wash, Bronchial Brush, Lung Aspirate, Naso-pharyngeal aspirate (NPA), Chest tube aspirate
| | - Gram stain, Culture bacterial aerobic, anaerobic and fungal (yeasts) with isolation, identification & Susceptibility tests of isolate. Vitek2 and Vitek MS
| D-MD-LAB-09-180/956/701/702/706/513/510/102 | Active
|
- Colonic Wash, Colostomy, Duodenal Aspirate, Gastric Aspirate, Rectal Swab, Stool
| | - Culture stool, aerobic with isolation, identification and susceptibility for Salmonella spps. Shigella spps. , other significant Entero pathogens viz. E. coli 0157. Identification of Campylobacter. Vitek2 and Vitek MS
| D-MD-LAB-09-202/506/701/702/706/510 | Active
|
| | - Culture bacterial, anaerobic, with isolation, identification and susceptibility performed for the pathogen isolated.Vitek2 and Vitek MS
| D-MD-LAB-09-178/506/510 | Active
|
| | - Gram stain, Culture bacterial aerobic and anaerobic, identification & Susceptibility tests of isolates.
| D-MD-LAB-09-506/178/701/702/706/513/510/102 | Active
|
| | - Detection of Trichomonas vaginalis from vaginal specimens
| D-MD-LAB-09-129 | Active
|
| | - Urinalysis by dip-stick and microscopy by IRIS Auto-analyzer, Vitek2 and Vitek MS
| D-MD-LAB-09-906 | Active
|
- Urine specimens - Catheter, Clean Catch Midstream, Pedi bag, Kidney, Nephrostomy, Suprapubic, Ureter
| | - Culture bacterial, aerobic and anaerobic in selected collection types. Identification & Susceptibility tests of isolates.
| D-MD-LAB-09-903/904/701/702/706/513/510 | Active
|
| | - Culture bacterial, aerobic isolate, additional methods required for definitive identification and susceptibility.
| D-MD-LAB-09-202/701/706/510/513 | Active
|
- Stool specimens should be collected in Cary Blair transport media
| - FilmArray® Gastrointestinal Panel
| | D-MD-LAB-09-816 | Active
|
- Sputum-like specimens or bronchoalveolar lavage (BAL)-like specimens
| - FilmArray® Pneumonia plus Panel
| | D-MD-LAB-09-815 | Active
|
- Nasopharyngeal Swab in UTM (NPS)
| - FilmArray® Respiratory 2.1 Panel
| | D-MD-LAB-09-813 | Active
|
- Female -: Urine, Vaginal swab, uretharl swab, Endocervical swab
| - Chlamydia trachomatis and Neisseria gonorrhoeae
| | D-MD-LAB-09-808 | Active
|
| - Mycobacterium tuberculosis (drug sensitive and drug resistant)
| D-MD-LAB-09-810 | Active
|
- Nasal aspirate, Nasal wash, Nasopharyngeal swab, Nasal swab
| | D-MD-LAB-09-809 | Active
|
| | D-MD-LAB-09-804 | Active
|
| Molecular Microbiology |
- Positive culture from Microbiology
| | - Strip Assay -Reverse Hybridization ABI 7900-
| D-MD-LAB-12-213 | Active
|
- BAL, 5 ml or UTM Flocked Swab, Blood
| | | D-MD-LAB-12-201 | Active
|
| | - Strip Assay -Reverse Hybridization ABI 7900
| D-MD-LAB-12-304 | Active
|
| - CMV quantitative PCR, Urine
| - Realtime PCR BIORAD CFX 96
| D-MD-LAB-12-210 | Active
|
| - Cytomegalovirus quantitative PCR
| D-MD-LAB-12-210 | Active
|
- EDTA Gel Plasma, 2 full EDTA Gel tubes (4 ml plasma)
| | | D-MD-LAB-12-220 | Active
|
| D-MD-LAB-12-221 | Active
|
| D-MD-LAB-12-222 | Active
|
| - Mycobacterium tuberculosis PCR
| | D-MD-LAB-12-224 | Active
|
- Respiratory specimens, UTM swab
| - Respiratory pathogen detection by Allplex PCR
| - Realtime PCR BIORAD CFX 96
| D-MD-LAB-12-218 | Active
|
| | - Capillary Electrophoresis
| D-MD-LAB-12-311 | Active
|
- Epstein Barr virus quantitative PCR
| - Realtime PCR BIORAD CFX 96
| D-MD-LAB-12-225 | Active
|
| | PL-MOL-PR-074 | Active
|
- EDTA blood ( plasma Separated within 4 hours )
| - Polyomavirus (BK) quantitative PCR
| PL-MOL-PR-075 | Active
|
| - Polyomavirus (BK) quant UrinePCR
| PL-MOL-PR-075 | Active
|
- Cervical cells collected in preservcyte
| | PL-MOL-PR-076 | Active
|
| - Herpes Simplex virus genotype/VZV PCR
| PL-MOL-PR-072 | Active
|
| Clinical Pathology |
- Tempus Blood, EDTA Gel Blood, 5 ml
| - BCR-ABL1 Quantitative PCR
| | D-MD-LAB-12-310 Cepheid
D-MD-LAB-12-302 IS-MMR | Active
|
| | - Strip Assay -Reverse Hybridization ABI 7900
| D-MD-LAB-12-305 | Active
|
| D-MD-LAB-12-305 | Active
|
- Tempus Blood, EDTA Gel Blood or EDTA Bone Marrow Aspirate
| - PML-RARA Translocation PCR
| | D-MD-LAB-12-307 | Active
|
| | - Strip Assay -Reverse Hybridization ABI 7900
| D-MD-LAB-12-305 | Active
|
- Tempus Blood, EDTA Gel Blood or EDTA Bone Marrow Aspirate
| | - Realtime PCR BIORAD CFX 96
| D-MD-LAB-12-312 | Active
|